Anti-Blood Group Antigen Lewis B, clone SPM194

Anti-Blood Group Antigen Lewis B, clone SPM194
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NEO-2525-MSM1X-P1ABX 100 µg - -

10 - 14 Werktage*

704,00 €
 
Formulation: Purified Ab WITHOUT BSA and Azide at 1.0mg/ml. Cellular Localization: Golgi... mehr
Produktinformationen "Anti-Blood Group Antigen Lewis B, clone SPM194"
Formulation: Purified Ab WITHOUT BSA and Azide at 1.0mg/ml. Cellular Localization: Golgi apparatus, Golgi stack membrane. Positive Control: Colon. Chromosome Location: 19p13.3. Protein Function: Catalyzes the transfer of L-fucose, from a guanosine diphosphate-beta-L-fucose, to both the subterminal N-acetyl glucosamine (GlcNAc) of type 1 chain (beta-D-Gal-(1->3)-beta-D-GlcNAc) glycolipids and oligosaccharides via an alpha(1,4) linkage, and the subterminal glucose (Glc) or GlcNAc of type 2 chain (beta-D-Gal-(1->4)-beta-D-GlcNAc) oligosaccharides via an alpha(1,3) linkage, independently of the presence of terminal alpha-L-fucosyl-(1,2) moieties on the terminal galactose of these acceptors (PubMed:11058871, PubMed:12668675, PubMed:1977660). Through its catalytic activity, participates in the synthesis of antigens of the Lewis blood group system, i.e. Lewis a (Le(a)), lewis b (Le(b)), Lewis x/SSEA-1 (Le(x)) and lewis y (Le(y)) antigens (PubMed:11058871, PubMed:12668675, PubMed:1977660). Also catalyzes the transfer of L-fucose to subterminal GlcNAc of sialyl- and disialyl-lactotetraosylceramide to produce sialyl Lewis a (sLe(a)) and disialyl Lewis a via an alpha(1,4) linkage and therefore may regulate cell surface sLe(a) expression and consequently regulates adhesive properties to E-selectin, cell proliferation and migration (PubMed:11058871, PubMed:12668675, PubMed:27453266). Catalyzes the transfer of an L-fucose to 3'-sialyl-N-acetyllactosamine by an alpha(1,3) linkage, which allows the formation of sialyl-Lewis x structure and therefore may regulate the sialyl-Lewis x surface antigen expression and consequently adhesive properties to E-selectin (PubMed:11058871, PubMed:29593094). Prefers type 1 chain over type 2 acceptors (PubMed:7721776). Type 1 tetrasaccharide is a better acceptor than type 1 disaccharide suggesting that a beta anomeric configuration of GlcNAc in the substrate is preferred (PubMed:7721776). Lewis-positive (Le(+)) individuals have an active enzyme while Lewis-negative (Le(-)) individuals have an inactive enzyme (PubMed:1977660) [The Uniprot Consortium]
Schlagworte: Anti-FUT3, Anti-Fucosyltransferase 3, Anti-Fucosyltransferase III, Anti-Alpha-3-fucosyltransferase FUT3, Anti-Blood group Lewis alpha-4-fucosyltransferase, Anti-4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase, Anti-3-galactosyl-N-acetylglu
Hersteller: NeoBiotechnologies
Hersteller-Nr: 2525-MSM1XABX

Eigenschaften

Anwendung: IF, IHC
Antikörper-Typ: Monoclonal
Klon: SPM194
Konjugat: No
Wirt: Mouse
Spezies-Reaktivität: guinea pig, human
MW: 45 kD
Format: Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-Blood Group Antigen Lewis B, clone SPM194"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen